However, it is now clear that CD4+ T-cell can kill tumor cells through direct cell contact via FasL- and TRAIL-dependent pathways, as well as through the perforin/granzyme B pathway, which is classically associated with cytotoxic CD8+ T-cells [57,58,59]. Here, GZMB is linked to neoplasm.